Search
ALPS Medical Breakthroughs ETF
SBIOAdd to Watchlist
55.780USD
+2.950+5.58%
Close 11-06 16:00（ET）
322.00Volume
17.52KTurnover
Today
+5.58%
5 Days
+1.66%
1 Month
+3.05%
6 Months
+1.03%
Year to Date
+8.90%
1 Year
+26.40%
Key Figures
52.920Open
52.830Prev. Close
55.920High
52.920Low
322.00Volume
17.52KTurnover
0.07Volume Ratio
70.85052wk High
44.05052wk Low
42.04KAvg Volume
--Div Yield
--Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
53.330NAV
USDNAV Currency
3.15P/B
--Price to earnings ratio
ALPS Medical Breakthroughs ETF Profile
Ticker SymbolSBIO
Asset ClassEquity
Fund ManagerALPS
DomicileUS
Expense Ratio0.50%
Founded at2014-12-31
Tracking IndexS-Network Medical Breakthroughs Index
SBIO was created on 2014-12-31 by ALPS. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 186.92m in AUM and 102 holdings. SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
VeraDermics Inc.
MANE
138.780
+10.180
+7.92%
52.68K
3.97%
$7.31M
CG oncology Inc.
CGON
75.990
+11.190
+17.27%
111.79K
3.75%
$6.90M
Oruka Therapeutics Inc.
ORKA
102.860
+6.840
+7.12%
83.51K
3.64%
$6.69M
4
Definium Therapeutics Inc.
DFTX
33.270
+2.910
+9.58%
169.42K
3.28%
$6.04M
5
Travere Therapeutics Inc.
TVTX
49.600
+0.730
+1.49%
118.87K
3.24%
$5.95M
6
Dianthus Therapeutics Inc.
DNTH
86.030
+3.020
+3.64%
70.50K
2.94%
$5.41M
7
Edgewise Therapeutics Inc.
EWTX
45.040
+6.170
+15.87%
136.92K
2.93%
$5.38M
8
Relay Therapeutics Inc.
RLAY
18.600
+1.600
+9.41%
276.31K
2.73%
$5.02M
9
Xenon Pharmaceuticals Inc.
XENE
39.170
+1.490
+3.95%
122.09K
2.35%
$4.31M
10
Amylyx Pharmaceuticals Inc.
AMLX
29.500
+1.880
+6.81%
158.28K
2.34%
$4.31M
ALPS Medical Breakthroughs ETF Technical Analysis
Technical Indicators
Buy
Summary
Neutral
Moving Average
Neutral
ALPS Medical Breakthroughs ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of ALPS Medical Breakthroughs ETF (SBIO)?
The current price of ALPS Medical Breakthroughs ETF (SBIO) is 55.78. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of ALPS Medical Breakthroughs ETF?
The 52-week high of ALPS Medical Breakthroughs ETF is 70.85. Please refer to the page timestamp for the latest data.
What is the 52-week low of ALPS Medical Breakthroughs ETF?
The 52-week low of ALPS Medical Breakthroughs ETF is 44.05. Please refer to the page timestamp for the latest data.
What is the NAV of ALPS Medical Breakthroughs ETF?
The NAV of ALPS Medical Breakthroughs ETF is 53.33 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is ALPS Medical Breakthroughs ETF (SBIO) performing?
The trading turnover of ALPS Medical Breakthroughs ETF (SBIO) is 17.52K. Its price changed by 3.58% over the past month, while its one-year return is 25.52%. View the ALPS Medical Breakthroughs ETF price chart for more details.
Is ALPS Medical Breakthroughs ETF (SBIO) a safe investment?
No investment is completely risk-free. The risk level of ALPS Medical Breakthroughs ETF (SBIO) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.